Soni Medicare Ltd
₹ 101
-5.00%
27 Nov
- close price
- Market Cap ₹ 43.0 Cr.
- Current Price ₹ 101
- High / Low ₹ 114 / 29.5
- Stock P/E
- Book Value ₹ 0.19
- Dividend Yield 0.00 %
- ROCE 6.64 %
- ROE -13.1 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 537 times its book value
- Company has low interest coverage ratio.
- Company has a low return on equity of -33.7% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.37 | 16.76 | 15.35 | 13.09 | 12.61 | 13.65 | 14.29 | 14.68 | 22.60 | 27.53 | 27.25 | 29.84 | 29.31 | |
| 10.66 | 15.28 | 14.23 | 12.05 | 11.49 | 13.20 | 14.19 | 14.04 | 22.44 | 27.74 | 28.77 | 29.92 | 28.77 | |
| Operating Profit | 1.71 | 1.48 | 1.12 | 1.04 | 1.12 | 0.45 | 0.10 | 0.64 | 0.16 | -0.21 | -1.52 | -0.08 | 0.54 |
| OPM % | 13.82% | 8.83% | 7.30% | 7.94% | 8.88% | 3.30% | 0.70% | 4.36% | 0.71% | -0.76% | -5.58% | -0.27% | 1.84% |
| 0.14 | 0.25 | 0.28 | 0.37 | -0.27 | 0.24 | 0.58 | 0.27 | 0.67 | 0.96 | 1.27 | 1.35 | 0.00 | |
| Interest | 0.96 | 0.85 | 0.41 | 0.47 | 0.53 | 0.53 | 0.65 | 0.79 | 0.72 | 0.71 | 0.85 | 0.99 | 1.05 |
| Depreciation | 0.57 | 0.58 | 0.77 | 0.79 | 0.74 | 0.76 | 0.76 | 0.74 | 0.78 | 0.66 | 0.52 | 0.50 | 0.53 |
| Profit before tax | 0.32 | 0.30 | 0.22 | 0.15 | -0.42 | -0.60 | -0.73 | -0.62 | -0.67 | -0.62 | -1.62 | -0.22 | -1.04 |
| Tax % | 31.25% | 26.67% | 18.18% | 40.00% | -173.81% | 11.67% | 73.97% | -8.06% | -10.45% | 9.68% | 3.09% | -18.18% | |
| 0.22 | 0.22 | 0.18 | 0.10 | 0.31 | -0.67 | -1.27 | -0.57 | -0.60 | -0.67 | -1.68 | -0.19 | -0.99 | |
| EPS in Rs | 0.52 | 0.52 | 0.42 | 0.23 | 0.73 | -1.57 | -2.98 | -1.34 | -1.41 | -1.57 | -3.94 | -0.45 | -2.32 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 16% |
| 3 Years: | 10% |
| TTM: | 2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 13% |
| 3 Years: | 19% |
| TTM: | 55% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 23% |
| 3 Years: | 45% |
| 1 Year: | 173% |
| Return on Equity | |
|---|---|
| 10 Years: | -9% |
| 5 Years: | -22% |
| 3 Years: | -34% |
| Last Year: | -13% |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.26 | 4.26 | 4.26 | 4.26 | 4.26 | 4.26 | 4.26 | 4.26 | 4.26 | 4.26 | 4.26 | 4.26 | 4.26 |
| Reserves | 2.55 | 2.53 | 2.37 | 2.50 | 2.82 | 2.15 | 0.88 | 0.31 | -0.29 | -0.97 | -2.65 | -2.97 | -4.18 |
| 5.70 | 4.34 | 3.33 | 4.10 | 3.98 | 5.32 | 6.11 | 7.12 | 7.34 | 8.72 | 9.77 | 10.52 | 11.10 | |
| 3.39 | 3.18 | 3.37 | 3.22 | 2.86 | 3.11 | 5.13 | 5.31 | 7.58 | 8.08 | 8.29 | 10.35 | 12.66 | |
| Total Liabilities | 15.90 | 14.31 | 13.33 | 14.08 | 13.92 | 14.84 | 16.38 | 17.00 | 18.89 | 20.09 | 19.67 | 22.16 | 23.84 |
| 7.35 | 7.71 | 8.03 | 7.54 | 6.93 | 7.02 | 6.96 | 6.60 | 6.68 | 6.42 | 6.17 | 6.33 | 6.21 | |
| CWIP | 0.73 | 0.00 | 0.00 | 0.00 | 0.35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.01 | 0.01 | 0.01 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| 7.81 | 6.59 | 5.29 | 6.49 | 6.59 | 7.77 | 9.37 | 10.35 | 12.17 | 13.63 | 13.46 | 15.79 | 17.59 | |
| Total Assets | 15.90 | 14.31 | 13.33 | 14.08 | 13.92 | 14.84 | 16.38 | 17.00 | 18.89 | 20.09 | 19.67 | 22.16 | 23.84 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.71 | 4.90 | 0.32 | -0.07 | 1.36 | 0.67 | -0.13 | 3.27 | -2.31 | 0.21 | 0.39 | 1.47 | |
| 1.14 | -0.29 | -1.16 | -0.27 | -0.29 | -0.47 | -0.65 | -0.29 | -0.73 | -0.25 | -0.17 | -0.52 | |
| -0.67 | -5.12 | 0.51 | 0.06 | -0.84 | 0.33 | 0.49 | -2.87 | 2.72 | 0.31 | 0.21 | -0.24 | |
| Net Cash Flow | -0.24 | -0.51 | -0.33 | -0.27 | 0.23 | 0.53 | -0.29 | 0.11 | -0.32 | 0.27 | 0.43 | 0.71 |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 16.23 | 12.85 | 17.83 | 60.23 | 48.92 | 49.20 | 77.39 | 98.96 | 101.10 | 103.68 | 94.97 | 107.15 |
| Inventory Days | 426.67 | 164.15 | 100.72 | 167.99 | 232.08 | 328.50 | 234.43 | 156.24 | 36.30 | 20.76 | 23.77 | 38.26 |
| Days Payable | 211.45 | 114.77 | 128.92 | 226.03 | 276.39 | 306.60 | 406.54 | 371.73 | 241.18 | 225.75 | 223.30 | 288.90 |
| Cash Conversion Cycle | 231.45 | 62.23 | -10.37 | 2.20 | 4.61 | 71.10 | -94.72 | -116.54 | -103.78 | -101.31 | -104.57 | -143.49 |
| Working Capital Days | 31.28 | -72.52 | -71.10 | -46.01 | -52.68 | -49.74 | -27.84 | -86.03 | -6.94 | 0.27 | 28.40 | 17.00 |
| ROCE % | 9.98% | 9.90% | 5.97% | 5.96% | 4.65% | -0.61% | -0.70% | 1.48% | 0.35% | 0.77% | -6.58% | 6.64% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
15 Nov - Extracts of the Unaudited Financial Results for the Quarter and half year ended 30th September 2025 has been published by the company in 15th November …
-
Results-Financial Results For Half Year Ended And Quarter Ended For Sept 30 2025
14 Nov - Unaudited Q2/H1 results ended 30 Sep 2025: H1 revenue Rs1,400.86 lakh; H1 net loss Rs121.05 lakh; limited review.
-
Board Meeting Outcome for Outcome Of Board Meeting Held On 14Th November, 2025 Pursuant To Regulation 30 Of SEBI (LODR) Regulations, 2015.
14 Nov - Board approved unaudited Q2/H1 results ended 30 Sep 2025; H1 net loss Rs121.05 lakh.
-
Board Meeting Intimation for Declaration Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2025
10 Nov - Board meeting 14 Nov 2025 to approve unaudited results for quarter/half year ended 30 Sep 2025.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
13 Oct - Registrar certificate under Reg 74(5) for quarter ended 30 Sep 2025 confirming demat confirmations.
Business Overview:[1]
Company runs Soni Hospital which is a 100 bed Corporate Multispecialty Hospital with NABH accreditation. It houses a modern women’s health & well-being centre for mother & child by the name JOY. SML provides equipment and facilities to patients for advance comfortable treatment processors in Cardiac, CT, and MRI etc.